# REGULATION OF VGF BY NEUROTROPHIC GROWTH FACTORS

> **NIH NIH R01** · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · 1991 · $156,550

## Abstract

In addition to their role in the growth, development and maintenance of
normal brain structure and function, neurotrophic growth factors have been
implicated in neurodegenerative disorders.  The overall goal of the
proposed study is to gain an understanding of the molecular mechanisms by
which neurotrophic growth factors act to regulate gene expression during
neural development, degeneration and regeneration.  These investigations
have been facilitated through studies of the effects of NGF on PC12
pheochromocytoma cells, a cell line of adrenal origin that responds to NGF,
but not EGF, by extending neurities and becoming electrically excitable.
Using subtractive screening methods, we have cloned and characterized an
mRNA that is rapidly, transiently and selectively regulated in PC12 cells
by the neurotrophic growth factors NGF and basic fibroblast growth factor
(bFGF), but not by EGF and insulin.  This clone, NGF33.1, corresponds to an
mRNA (VGF) that is nervous system-specific with peak levels found in
developing and adult central and peripheral nervous tissues.  VGF is
therefore the most rapidly and selectively regulated neural mRNA yet
identified; in addition, VGF mRNA is reinduced following readdition of NGF
to neuronally-differentiated PC12 cells that were previously washed and
deprived of NGF.  We propose to use the VGF gene as a model to investigate
the early events and the selective actions of NGF and bFGF in neural
differentiation and in regeneration following neuronal injury.  We have
cloned and fully sequenced the VGF gene; transcriptional and post-
transcriptional regulation of VGF gene expression will be investigated by
transfection analysis and studies of VGF mRNA stability.  The neural-
specific expression of VGF mRNA during development will be further
characterized using in situ hybridization, more extensive RNase protection
analysis, and through the production of transgenic mice.  We propose to
study the function of the polypeptide encoded by the VGF gene by
transfecting eukaryotic expression vectors, containing the VGF coding
sequence in sense and anti-sense orientations, into PC12 cells, and by
characterizing the effect(s) of antisera, generated against the encoded VGF
polypeptide, and anti-sense oligonucleotides on PC12 cells and primary
neural cultures.  Further characterization of the VGF gene and encoded
polypeptide offers a unique opportunity to assess the rapid but selective
mechanism(s) by which NGF and bFGF and possibly other neurotrophic growth
factors trigger neural differentiation, support neuronal function in the
CNS and PNS, and modulate neuronal regeneration after injury.

## Key facts

- **NIH application ID:** 3122613
- **Project number:** 1R01AG010676-01
- **Recipient organization:** MOUNT SINAI SCHOOL OF MEDICINE OF CUNY
- **Principal Investigator:** STEPHEN R SALTON
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 1991
- **Award amount:** $156,550
- **Award type:** 1
- **Project period:** 1991-09-29 → 1996-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/3122613

## Citation

> US National Institutes of Health, RePORTER application 3122613, REGULATION OF VGF BY NEUROTROPHIC GROWTH FACTORS (1R01AG010676-01). Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/grant/nih/3122613. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
